ADIPOQ and Insulin resistance: The present results indicate that insulin resistance, but not visceral adiposity or reduction in serum adiponectin, might be independently associated with increased XOR activity, thus suggesting that development of insulin resistance resulting from increased visceral adiposity and/or reduced serum adiponectin may contribute to hyperuricemia by stimulating XOR activity.